In a recent paper from Chen et al. [146], through an accurate analysis of publicly available microarray datasets (Gene Expression Omnibus database), HCG18 and MCM3AP-AS1 lncRNAs have been proposed as novel biomarkers of PCa progression, since they resulted in being positively associated with bone metastasis, increased abundance of M2 Macrophage infiltration and poor prognosis. The gene discussed is HCG18; the disease is posterior cortical atrophy.